Article

Functional inactivation of the WTX gene is not a frequent event in Wilms’ tumors

Department of Experimental Oncology and Laboratories, Genetic Susceptibility to Cancer Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Oncogene (Impact Factor: 8.56). 05/2008; 27(33):4625-32. DOI: 10.1038/onc.2008.93
Source: PubMed

ABSTRACT For many years the precise genetic etiology of the majority of Wilms' tumors has remained unexplained. Recently, the WTX gene, mapped to chromosome Xq11.1, has been reported to be lost or mutated in approximately one-third of Wilms' tumors. Moreover, in female cases, the somatically inactivated alleles were found to invariantly derive from the active chromosome X. Consequently, WTX has been proposed as a 'one-hit' tumor suppressor gene. To provide further insights on the contribution of WTX to the development of the disease, we have examined 102 Wilms' tumors, obtained from 43 male and 57 female patients. Quantitative PCR analyses detected WTX deletions in 5 of 45 (11%) tumors from males, whereas loss of heterozygosity at WTX-linked microsatellites was observed in 9 tumors from 50 informative females (19%). However, in the latter group, using a combination of HUMARA assay and bisulfite-modified DNA sequencing, we found that the deletion affected the active chromosome X only in two cases (4%). Sequence analyses detected an inactivating somatic mutation of WTX in a single tumor, in which a strongly reduced expression of the mutant allele respect to the wild-type allele was observed, a finding not consistent with its localization on the active chromosome X. Overall, a functional somatic nullizygosity of the WTX gene was ascertained only in seven of the Wilms' tumors included in the study (approximately 7%). Our findings indicate that previously reported estimates on the proportion of Wilms' tumors due to WTX alterations should be reconsidered.

Download full-text

Full-text

Available from: Monica Terenziani, Apr 08, 2014
0 Followers
 · 
124 Views
  • Source
    • "As XIST is transcribed only from Xi, loss of Xi in T25 and T36 was confirmed by measuring XIST expression using QPCR (Figure 4). Therefore, events involving WTX do not selectively occur on the Xa, as previously assumed (Perotti et al., 2008). Two malederived tumours with WTX deletions (T7, T21) had low WTX expression (Figure 3c), whereas the third tumour (T22) had detectable levels of WTX expression (Figure 3c). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Wilms tumours (WTs) have two distinct types of histology with or without ectopic mesenchymal elements, suggesting that WTs arise from either the mesenchymal or epithelial nephrogenic lineages. Regardless of the presence or absence of CTNNB1 mutations, nuclear accumulation of beta-catenin is often observed in WTs with ectopic mesenchymal elements. Here, we addressed the relationship between the WNT-signalling pathway and lineage in WTs by examining CTNNB1 and WT1 mutations, nuclear accumulation of beta-catenin, tumour histology and gene expression profiles. In addition, we screened for mutations in WTX, which has been proposed to be a negative regulator of the canonical WNT-signalling pathway. Unsupervised clustering analysis identified two classes of tumours: mesenchymal lineage WNT-dependent tumours, and epithelial lineage WNT-independent tumours. In contrast to the mesenchymal lineage specificity of CTNNB1 mutations, WTX mutations were surprisingly observed in both lineages. WTX-mutant WTs with ectopic mesenchymal elements had nuclear accumulation of beta-catenin, upregulation of WNT target genes and an association with CTNNB1 mutations in exon 7 or 8. However, epithelial lineage WTs with WTX mutations had no indications of active WNT signalling, suggesting that the involvement of WTX in the WNT-signalling pathway may be lineage dependent, and that WTX may have an alternative function to its role in the canonical WNT-signalling pathway.
    Oncogene 02/2009; 28(8-8):1063-75. DOI:10.1038/onc.2008.455 · 8.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Retinoblastoma and Wilms’ tumor represent two childhood tumors with both sporadic and familial forms. Delineation of the molecular etiology of these cancers identified the retinoblastoma gene Rb as the first example of a tumor suppressor gene and provided the first example of imprinting and cancer predisposition in Wilms’ tumor. In this chapter, we review the clinical features and genetics of these two disorders and the implications for management, early detection and potential prevention of these disorders. KeywordsRetinoblastoma-Wilms tumor-WT1 gene-RB1 gene-Cell cycle-Beckwith Wiedemann syndrome-WTX gene-Knudsen hypothesis
    01/1970: pages 163-180;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abnormalities in WNT signaling are implicated in a broad range of developmental anomalies and also in tumorigenesis. Here we demonstrate that germline mutations in WTX (FAM123B), a gene that encodes a repressor of canonical WNT signaling, cause an X-linked sclerosing bone dysplasia, osteopathia striata congenita with cranial sclerosis (OSCS; MIM300373). This condition is typically characterized by increased bone density and craniofacial malformations in females and lethality in males. The mouse homolog of WTX is expressed in the fetal skeleton, and alternative splicing implicates plasma membrane localization of WTX as a factor associated with survival in males with OSCS. WTX has also been shown to be somatically inactivated in 11-29% of cases of Wilms tumor. Despite being germline for such mutations, individuals with OSCS are not predisposed to tumor development. The observed phenotypic discordance dependent upon whether a mutation is germline or occurs somatically suggests the existence of temporal or spatial constraints on the action of WTX during tumorigenesis.
    Nature Genetics 01/2009; 41(1):95-100. DOI:10.1038/ng.270 · 29.65 Impact Factor
Show more